Lanean...
The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
The Women’s Health Initiative (WHI), a landmark randomized trial of menopausal hormone therapy (HT) for prevention of chronic disease in postmenopausal women aged 50–79, established that such therapy neither prevents coronary heart disease (CHD) nor yields a favorable balance of benefits and risks i...
Gorde:
| Argitaratua izan da: | Metabolism |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4834454/ https://ncbi.nlm.nih.gov/pubmed/27085786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.metabol.2016.01.004 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|